124 related articles for article (PubMed ID: 219284)
1. Prevention of spontaneous leukemia in AKR mice by passive immunization and type specificity of this protection.
Fish DC; Gilden RV; Bare RM; Trimmer RM; Huebner RJ
J Natl Cancer Inst; 1979 Apr; 62(4):943-5. PubMed ID: 219284
[TBL] [Abstract][Full Text] [Related]
2. Prevention of paralysis and suppression of lymphoma in wild mice by passive immunization to congenitally transmitted murine leukemia virus.
Gardner MB; Estes JD; Casagrande J; Rasheed S
J Natl Cancer Inst; 1980 Feb; 64(2):359-64. PubMed ID: 6243718
[TBL] [Abstract][Full Text] [Related]
3. Expression of antigens coded in murine leukemia viruses on thymocytes of allogeneic donor origin in AKR mice following syngeneic or allogeneic bone marrow transplantation.
Wustrow TP; Good RA
Cancer Res; 1985 Dec; 45(12 Pt 1):6428-35. PubMed ID: 2998600
[TBL] [Abstract][Full Text] [Related]
4. Prevention of spontaneous leukemia in AKR mice by type-specific immunosuppression of endogenous ecotropic virogenes.
Huebner RJ; Gilden RV; Toni R; Hill RW; Trimmer RW; Fish DC; Sass B
Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4633-5. PubMed ID: 188047
[TBL] [Abstract][Full Text] [Related]
5. [Spontaneous leukemia of AKR mice. Successful passive immunization with goat antibodies against isolated glycoprotein gp71 of Friend leukemia virus].
Schwarz H; Thiel HJ; Schäfer W
Z Naturforsch C Biosci; 1977; 32(5-6):459-61. PubMed ID: 141818
[TBL] [Abstract][Full Text] [Related]
6. Suppression of infectious murine leukemia virus in wild mice (Mus musculus) by passive immunization.
Gardner MB; Klement V; Estes JD; Gilden RV; Toni R; Huebner RJ
J Natl Cancer Inst; 1977 Jun; 58(6):1855-7. PubMed ID: 194048
[TBL] [Abstract][Full Text] [Related]
7. Properties of mouse leukemia viruses. XVII. Factors required for successful treatment of spontaneous AKR leukemia by antibodies against gp71.
Schwarz H; Ihle JN; Wecker E; Fischinger PJ; Thiel HJ; Bolognesi DP; Schäfer W
Virology; 1981 Jun; 111(2):568-78. PubMed ID: 6264673
[No Abstract] [Full Text] [Related]
8. Suppressed murine mammary tumor virus (MuMTV) expression in RIII female mice treated neonatally with goat antiserum to MuMTV.
Frensdorff A; Wald A
J Natl Cancer Inst; 1978 Aug; 61(2):437-9. PubMed ID: 210290
[TBL] [Abstract][Full Text] [Related]
9. Treatment of spontaneous leukemia in AKR mice with chemotherapy, immunotherapy, or interferon.
Bekesi JG; Roboz JP; Zimmerman E; Holland JF
Cancer Res; 1976 Feb; 36(2 pt 2):631-9. PubMed ID: 1082796
[TBL] [Abstract][Full Text] [Related]
10. The effects of passive antiviral immunotherapy in AKR mice: I. The susceptibility of AKR mice to spontaneous and induced T cell lymphomagenesis.
Haran-Ghera N; Peled A; Wu L; Shortman K; Brightman BK; Fan H
Leukemia; 1995 Jul; 9(7):1199-206. PubMed ID: 7630195
[TBL] [Abstract][Full Text] [Related]
11. Genes of the H-2 complex regulate the antibody response to murine leukemia virus.
Vlug A; Schoenmakers HJ; Melief CJ
J Immunol; 1981 Jun; 126(6):2355-60. PubMed ID: 6262410
[TBL] [Abstract][Full Text] [Related]
12. Prevention of 334C murine virus-induced leukemia by transmission of maternal immunity to offspring.
Buffett RF
Cancer Res; 1974 Mar; 34(3):559-63. PubMed ID: 4359879
[No Abstract] [Full Text] [Related]
13. Neonate-primed CD8+ memory cells rival adult-primed memory cells in antigen-driven expansion and anti-viral protection.
Fadel SA; Cowell LG; Cao S; Ozaki DA; Kepler TB; Steeber DA; Sarzotti M
Int Immunol; 2006 Feb; 18(2):249-57. PubMed ID: 16418189
[TBL] [Abstract][Full Text] [Related]
14. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
[TBL] [Abstract][Full Text] [Related]
15. Immunity to viral leukemia in rats and the routes of transmission from mother to offspring.
Ioachim HL; Keller SE; Gimovsky ML; Shepherd S
Cancer Res; 1973 Mar; 33(3):547-50. PubMed ID: 4570272
[No Abstract] [Full Text] [Related]
16. Correlation of early murine leukemia virus titer and H-2 type with spontaneous leukemia in mice of the BALB/c times AKR cross: a genetic analysis.
Lilly F; Duran-Reynals ML; Rowe WP
J Exp Med; 1975 Apr; 141(4):882-9. PubMed ID: 165256
[TBL] [Abstract][Full Text] [Related]
17. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis.
Green WR; Nowinski RC; Henney CS
J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211
[No Abstract] [Full Text] [Related]
18. Immunotherapy of murine leukemia. II. Effect of passive serum therapy on Friend murine leukemia virus-induced hematologic and coagulation parameters.
Sanfilippo F; Kao KJ; Pizzo SV; Collins JJ
J Natl Cancer Inst; 1980 Mar; 64(3):547-53. PubMed ID: 6928240
[No Abstract] [Full Text] [Related]
19. Clonal heterogeneity of anti-AKR/gross leukemia virus cytotoxic T lymphocytes. Evidence for two distinct antigen systems.
Azuma H; Phillips JD; Green WR
J Immunol; 1987 Oct; 139(7):2464-73. PubMed ID: 2821116
[TBL] [Abstract][Full Text] [Related]
20. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens.
Zbar B; Manohar V; Sugimoto T; Ashley MP; Kato Y; Rappaport P
Cancer Res; 1981 Nov; 41(11 Pt 1):4499-507. PubMed ID: 6272979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
